Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

LDR meets $75m IPO target

This article was originally published in Clinica

Executive Summary

Spinal implant specialist LDR has launched its initial public offering (IPO), reportedly raising the $75m it had hoped for, selling five million shares at $15 apiece. The firm had previously upped its target from the $69m it had originally been aiming for (www.clinica.co.uk, 20 September 2013). The Austin, Texas company estimates that the net proceeds from the offering will be around $66.8m, or $77.2m if the underwriters exercise their overallotment option in full, it said in a filing with the US Securities and Exchange Commission (SEC). LDR will list on the Nasdaq Global Select market under the ticker symbol LDRH. The firm’s flagship products are based on its VerteBRIDGE fusion and Mobi non-fusion platforms, which are both designed for use in the cervical and lumbar spine.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT100942

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel